ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure
Open Access
- 4 March 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (3), 396
- https://doi.org/10.3390/antiox10030396
Abstract
Aims: Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a cornerstone of drug therapy after myocardial infarction (MI) and improve left ventricular function and survival. We aimed to elucidate the impact of early treatment with the ACE inhibitor ramipril on the hematopoietic response after MI, as well as on the chronic systemic and vascular inflammation. Methods and Results: In a mouse model of MI, induced by permanent ligation of the left anterior descending artery, immediate initiation of treatment with ramipril (10 mg/k/d via drinking water) reduced cardiac inflammation and the number of circulating inflammatory monocytes, whereas left ventricular function was not altered significantly, respectively. This effect was accompanied by enhanced retention of hematopoietic stem cells, Lin−Sca1−c-Kit+CD34+CD16/32+ granulocyte–macrophage progenitors (GMP) and Lin−Sca1−c-Kit+CD150−CD48− multipotent progenitors (MPP) in the bone marrow, with an upregulation of the niche factors Angiopoetin 1 and Kitl at 7 d post MI. Long-term ACE inhibition for 28 d limited vascular inflammation, particularly the infiltration of Ly6Chigh monocytes/macrophages, and reduced superoxide formation, resulting in improved endothelial function in mice with ischemic heart failure. Conclusion: ACE inhibition modulates the myeloid inflammatory response after MI due to the retention of myeloid precursor cells in their bone marrow reservoir. This results in a reduction in cardiac and vascular inflammation with improvement in survival after MI.Keywords
Funding Information
- Bundesministerium für Bildung und Forschung (01EO1503)
- Boehringer Ingelheim Stiftung (Experimental Vascular Biology Mainz)
This publication has 38 references indexed in Scilit:
- Myocardial infarction accelerates atherosclerosisNature, 2012
- Regulation of the Inflammatory Response in Cardiac RepairCirculation Research, 2012
- A New Era in Secondary Prevention after Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial InfarctionCirculation Research, 2010
- Effects of ACE2 Inhibition in the Post-Myocardial Infarction HeartJournal of Cardiac Failure, 2010
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory SitesScience, 2009
- NADPH oxidases and angiotensin II receptor signalingMolecular and Cellular Endocrinology, 2008
- Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the delapril remodeling after acute myocardial infarction (DRAMI) trialAmerican Heart Journal, 2003
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997